You are here
GLYCOSCIENTIFIC, L.L.C.
UEI: EUVNNWGFCA87
# of Employees: 5
HUBZone Owned: Yes
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Recognition of O-GlcNAc Modified Proteins Using Site-Specific Antibodies
Amount: $275,767.00Pulmonary arterial hypertension (PAH) is a progressive disorder characterized by high blood pressure (hypertension) in the arteries of the lungs (pulmonary artery) for no apparent reason. PAH is a dis ...
SBIRPhase I2023Department of Health and Human Services National Institutes of Health -
Development of Monoclonal Antibodies for the Study of Mycobacterium tuberculosis (Mtb) in the Guinea Pig
Amount: $600,000.00GlycoScientific proposes to generate antibodies specific for six inflammatory cytokines to elucidate and correlate immunological markers of tuberculosis (TB) transmission and disease development in th ...
SBIRPhase I2023Department of Health and Human Services National Institutes of Health -
Development of Isotopically Labeled Glycoproteins for use as Internal Standards
Amount: $697,095.00Project Summary/Abstract The ability to accurately quantitate the glycan chains attached to glycoproteins has wide-ranging implications. Numerous studies over the past 40 years have demonstrated that ...
STTRPhase II2020Department of Health and Human Services National Institutes of Health -
Isotopically Labeled Heparan Sulfate Glycosaminoglycan Disaccharides for use as Internal Standards
Amount: $252,114.00PROJECT SUMMARY/ABSTRACTSulfated glycosaminoglycan (GAG) carbohydrates represent one of the more structurally diverse groups of biomolecules, and a comprehensive understanding of their biological stru ...
STTRPhase I2020Department of Health and Human Services National Institutes of Health -
Creating Antibodies to Enable the Study of Mycobacterium Tuberculosis Infections in Guinea Pigs
Amount: $653,191.00Tuberculosis is a persistent infectious disease that threatens the health of people and numerous mammalian species throughout the worldMonitoring of Mycobacterium tuberculosisMtbinfections in animal m ...
SBIRPhase I2019Department of Health and Human Services National Institutes of Health -
Development of Site-specific Arg-GlcNAc Antibodies
Amount: $298,483.00Human pathogenic gram-negative bacteria, such as Escherichia coli (E. Coli) and Salmonella enterica cause millions of deaths, thousands of fatalities and billions of dollars in medical expenses and lo ...
SBIRPhase I2019Department of Health and Human Services National Institutes of Health -
Development of Site-specific O-GlcNAc Antibodies for Epigenetic Research
Amount: $1,110,831.00Project SummaryO glycosylation of nuclear and cytoplasmic proteins by a singleN acetyl D glucosamine moietyOGlcNAcis a common post translational modification that is highly dynamic and fluctuates in r ...
SBIRPhase II2017Department of Health and Human Services National Institutes of Health -
Generation of antibodies to monitor Notch O-fucosylation in vivo
Amount: $242,306.00Project Summary Notch is a cell surface protein that has diverse roles in human biology at all stages of life Notch is modified by a number of sugar structures including a number that are termed O ...
STTRPhase I2016Department of Health and Human Services National Institutes of Health -
Development of Isotopically Labeled Glycoproteins for use as Internal Standards
Amount: $270,251.00DESCRIPTION provided by applicant The ability to accurately quantitate the glycan chains attached to glycoproteins has wide ranging implications Numerous studies over the past years have demons ...
STTRPhase I2015Department of Health and Human Services National Institutes of Health -
Antibodies to O-GlcNAc modified histones for chromatin biology and epigenetic res
Amount: $349,180.00DESCRIPTION (provided by applicant): O-glycosylation of nuclear and cytoplasmic proteins by a single ?-N-acetyl-D-glucosamine moiety (O-GlcNAc) is a common post-translational modification that is hig ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health